Treatment of advanced pseudomyxoma peritonei using cytoreductive surgery including total gastrectomy and perioperative chemotherapy.

Published in: Journal of surgical oncology (2021)

A 10-year survival after cytoreductive surgery, total gastrectomy with temporary high diverting jejunostomy, and perioperative chemotherapy occurred in 58% of these patients with advanced pseudomyxoma peritonei. High-grade disease and extensive prior surgery with a high PSS were associated with reduced benefit.

Keyphrases

minimally invasive
coronary artery bypass
high grade
surgical site infection
patients undergoing
cardiac surgery
locally advanced
radiation therapy
coronary artery disease
chemotherapy induced
smoking cessation